Key Takeaways

• Ashwagandha reduces cortisol through HPA axis regulation; its primary depression mechanism. High cortisol suppresses hippocampal neurogenesis, disrupts serotonin synthesis, and reduces GABA activity, all directly implicated in depression.
• Ashwagandha does not raise serotonin directly. Its serotonin connection is indirect; cortisol reduction restores the tryptophan-to-serotonin pathway that chronic stress diverts toward inflammation.
• It is most likely to help stress-related and anxiety-driven depression. It is not a treatment for major depressive disorder and does not replace prescribed medication.
• “Can ashwagandha cause depression?” Some people experience emotional flatness at high doses due to cortisol suppression. This is dose-dependent and resolves with reduction.

Ashwagandha has genuine clinical evidence for mood and stress-related depression, but claims that it works like an antidepressant, raises serotonin directly, or treats clinical depression are not supported by current evidence. What the research shows is more specific and more useful: ashwagandha addresses the biological substrate of stress-driven depression (HPA axis overactivation and chronic cortisol elevation) through a mechanism distinct from pharmaceutical antidepressants.

This article explains which specific ashwagandha benefits are relevant to depression, what the evidence shows for each, who is most likely to benefit, and what the research actually says about serotonin, dosage, and safety alongside antidepressants. For the closely related anxiety application, the ashwagandha for anxiety article covers the anxiety-specific evidence and mechanisms in full.

Persistent or severe depression requires professional evaluation and treatment. The information in this article covers ashwagandha as a supplement and does not constitute medical advice. If you are experiencing depression that affects your ability to function, please speak with a healthcare professional.

Does Ashwagandha Help with Depression?

The short answer: yes, for a specific type of stress-related and cortisol-driven depression that often presents alongside anxiety, poor sleep, and burnout. The evidence is less clear for primary major depressive disorder with neurochemical pathology independent of stress.

The landmark clinical trial: Chandrasekhar et al. (2012), published in the Indian Journal of Psychological Medicine, randomized 64 adults with chronic stress to KSM-66 ashwagandha (300 mg twice daily) or placebo for 60 days. Results: 44% reduction in Perceived Stress Scale scores, 27.9% reduction in serum cortisol, and significant improvements in the depression and anxiety subscales of the DASS-21 (Depression, Anxiety, Stress Scales). This is the most cited ashwagandha mood trial and the foundational evidence for its depression application.

The distinction matters: the DASS-21 depression subscale measures dysphoria and hopelessness (symptoms that overlap with stress and anxiety), not the full clinical presentation of major depressive disorder. Ashwagandha’s benefit is strongest in the stress-depression presentation; it is not a substitute for antidepressant pharmacotherapy in moderate-to-severe MDD.

Key Benefits of Ashwagandha for Depression

Cortisol Reduction for Stress-Driven Depression

Chronic HPA axis overactivation and sustained cortisol elevation are among the most consistent neurobiological findings in stress-triggered depression. High cortisol suppresses hippocampal neurogenesis (hippocampal volume is consistently reduced in clinical depression), diverts tryptophan away from serotonin synthesis toward the inflammatory kynurenine pathway, and reduces GABA receptor sensitivity, increasing neuronal excitability and anxious mood.

Ashwagandha withanolides reduce HPA axis reactivity, producing the 27.9% cortisol reduction documented in the Chandrasekhar trial. This is not a mild or marginal effect; nearly 30% less cortisol over 60 days directly addresses the neurobiological mechanisms most strongly associated with stress-related depression. For people who want to measure their cortisol before starting supplementation and track changes over time, an at-home cortisol test kit provides baseline and follow-up measurements without requiring a clinic visit. For the full context of cortisol and mental health, the article on how to lower cortisol naturally covers the HPA axis and its downstream effects on mood and sleep.

Serotonin Support: Does Ashwagandha Raise Serotonin?

This is the most searched question in the ashwagandha-depression cluster, and it requires a precise answer rather than a simple yes or no.

Ashwagandha is not a direct serotonergic agent. It does not inhibit serotonin reuptake (like SSRIs), act as a serotonin precursor (like 5-HTP), or significantly increase serotonin levels through direct pharmacological action. Expecting SSRI-equivalent serotonin effects from ashwagandha will produce disappointment.

What ashwagandha does do: it reduces cortisol, and high cortisol is one of the mechanisms that actively suppresses serotonin availability. When cortisol is elevated, the amino acid tryptophan (the raw material for serotonin synthesis) is diverted toward the kynurenine inflammatory pathway rather than the serotonin pathway. Cortisol reduction allows more tryptophan to be converted to serotonin through the normal metabolic route. Additionally, animal studies show withanolides modulate 5-HT2 receptor sensitivity, though robust human serotonin-specific RCT data is not yet available.

The practical implication: ashwagandha may meaningfully support serotonin availability in people whose low serotonin is secondary to chronic stress and HPA overactivation. For people with primary serotonin dysregulation independent of cortisol, the effect is much less clear.

Anxiety Relief for the Depression-Anxiety Overlap

Depression and anxiety co-occur in 50 to 60% of cases. For the majority of people searching “ashwagandha for depression,” the actual presentation includes significant anxiety alongside low mood. Ashwagandha addresses both components simultaneously through distinct mechanisms: HPA modulation for the stress-depression pathway and GABA-A receptor partial agonism for the anxiety component.

Withanolides partially agonize GABA-A receptors, the same receptors targeted by benzodiazepines, but with much lower affinity and without dependence risk at therapeutic doses. This produces the anxiolytic effect consistently documented in trials using the DASS-21, where all three subscales (depression, anxiety, and stress) improve, with anxiety and stress typically showing the largest response. For people managing anxiety-depression overlap, combining ashwagandha with structured mindfulness practice compounds the parasympathetic benefit. A guided meditation and breathing app provides a consistent daily practice that activates the same parasympathetic pathways ashwagandha supports at the receptor level.

Better Sleep, Better Mood

Sleep disruption both causes and worsens depression. Elevated cortisol fragments slow-wave sleep; poor sleep raises cortisol further; high cortisol deepens and prolongs depressive mood. This is a self-reinforcing cycle, and ashwagandha interrupts it at the cortisol node; the same intervention that benefits mood also benefits sleep through the shared mechanism.

Langade et al. (2019), published in Medicine, found KSM-66 (300 mg twice daily for 10 weeks) significantly improved sleep quality, sleep onset latency, and total sleep time in adults with chronic stress. In the depression context, where insomnia is a cardinal symptom, this benefit is directly therapeutic rather than a secondary bonus. For people looking to compound the sleep benefit with complementary ingredients, a nighttime recovery blend combining ashwagandha with magnesium and reishi provides multiple sleep-support mechanisms in a single evening product. For more on sleep as a lever for mood improvement, the article on how to get more deep sleep covers the sleep-cortisol-depression triangle in full.

BDNF Support and Neuroprotection

BDNF (brain-derived neurotrophic factor) is consistently low in depression and consistently increased by effective antidepressant treatments, regardless of drug class. BDNF-driven neurogenesis in the hippocampus is considered a central mechanism through which antidepressants produce their therapeutic effect over weeks rather than days.

Early research, primarily from animal models with limited human data, suggests ashwagandha increases BDNF expression in the hippocampus, the same region where BDNF-driven neurogenesis is most depressed in clinical depression. This is preliminary and should not be overstated as equivalent to antidepressant BDNF effects. But it adds biological plausibility to ashwagandha’s antidepressant potential beyond cortisol reduction alone, and suggests why some effects may persist after supplementation ends.

Does Ashwagandha Cause Depression?

This query receives significant search volume and reflects a genuine and common experience. Clinical trials have not documented depression as an adverse outcome from ashwagandha use, but some people who take it do report emotional flatness or worsening low mood. There are four distinct explanations:

• Emotional blunting at high doses: ashwagandha’s cortisol suppression and GABA-A agonism can produce reduced emotional reactivity at higher doses (above 600 mg/day in some individuals). This is a dose-dependent effect that some people experience as emotional flatness or numbness, which can be misinterpreted as worsening depression. Reducing the dose typically resolves this.
• Wrong subtype of depression: ashwagandha reduces cortisol. In people with low-cortisol presentations of depression (common in burnout, chronic fatigue, and some long-term depression presentations where the HPA axis has become hypoactivated rather than overactivated), further cortisol reduction can worsen fatigue and low mood. Ashwagandha is not appropriate for all depression presentations.
• Discontinuation rebound: stopping ashwagandha after extended use can cause temporary rebound anxiety and low mood as the HPA axis recalibrates. “Depression after stopping ashwagandha” is a temporary discontinuation effect, not evidence that ashwagandha caused depression.
• Undiagnosed bipolar disorder: adaptogens and HPA-modulating supplements can trigger mood instability in people with undiagnosed bipolar disorder. Significant mood swings, either elevated or depressed, after starting ashwagandha should prompt discussion with a psychiatrist.

Ashwagandha Dosage for Depression and Mood Support

Extract	Dose for mood support	Key characteristic
KSM-66	300 mg twice daily (600 mg/day)	Root only; most studied for stress and mood; 5% withanolides
Sensoril	250-500 mg/day	Root and leaf; higher withanolide per mg; 10% withanolides
Shoden	120-240 mg/day	35% withanolides; effective at much smaller dose

• Timing: evening dosing is most studied for cortisol and stress outcomes, aligning supplementation with the cortisol nadir. Some people prefer splitting the dose morning and evening.
• Duration: minimum 4 weeks to observe mood effects; most evidence comes from 8 to 12 week trials. Cortisol reduction is measurable at 4 weeks; mood and sleep improvements typically follow and compound over 8 to 12 weeks.
• Start low: 300 mg/day and increase to 600 mg/day after 2 weeks if tolerated. This reduces the risk of emotional blunting at high starting doses.

For a clinically standardised KSM-66 formulation, a root-extract ashwagandha supplement standardised to 5% withanolides provides the extract type used in the majority of mood-related clinical trials. For stacking options, ashwagandha pairs well with rhodiola for stress and fatigue (complementary adaptogen mechanisms) and with L-theanine for anxiety reduction (complementary GABA pathway support).

Can You Take Ashwagandha with Antidepressants?

No established clinically significant pharmacokinetic interaction exists between ashwagandha and common antidepressants (SSRIs, SNRIs, TCAs, or MAOIs). The primary caution is additive sedation: ashwagandha’s GABA-A activity combined with sedating antidepressants (mirtazapine, trazodone) or benzodiazepines may produce more sedation than expected.

Never reduce or stop prescribed antidepressant medication to substitute ashwagandha. Discontinuing antidepressants abruptly without medical supervision can cause discontinuation syndrome and mood destabilization. Always discuss supplement additions with your prescribing doctor before making any changes to your medication regimen.

The appropriate framing: ashwagandha can be considered a complement to existing treatment, not a replacement. For people on antidepressants who are experiencing high stress, poor sleep, and anxiety alongside managed depression, ashwagandha’s cortisol reduction may provide additional benefit through a mechanism antidepressants do not address directly. This is a conversation to have with a prescribing physician, not a decision to make unilaterally.

Ashwagandha Works Upstream of Depression

The case for ashwagandha benefits for depression is real but specific. It addresses the cortisol-driven mechanisms that sit upstream of serotonin dysregulation in stress-related depression: HPA overactivation, tryptophan diversion away from serotonin synthesis, hippocampal neurogenesis suppression, and GABA receptor hyposensitivity. For the anxiety-depression overlap that represents the majority of cases in people self-researching natural supplements, these mechanisms are directly relevant.

What it does not do: act as a direct antidepressant in the pharmacological sense, directly raise serotonin, or treat major depressive disorder with the efficacy of pharmaceutical antidepressants. The serotonin question has a real answer, indirect, via cortisol, and the “does ashwagandha cause depression” question has four mechanistic explanations that are worth understanding before starting. Both are more useful than the simple yes-or-no answers most articles provide.

Frequently Asked Questions

Does ashwagandha help with depression?

Yes, for stress-related and anxiety-driven depression. Multiple RCTs show improvements in depression subscale scores alongside cortisol reduction. It is not effective for major depressive disorder requiring pharmacological treatment.

Does ashwagandha raise serotonin?

Not directly. Ashwagandha reduces cortisol, which indirectly restores the tryptophan-to-serotonin conversion pathway that chronic stress diverts toward inflammation. It does not work like an SSRI or serotonin precursor.

Can ashwagandha cause depression?

Clinical trials have not found ashwagandha to cause depression. Some people experience emotional flatness at high doses from cortisol suppression. Those with low-cortisol depression presentations may find fatigue worsens. Discontinuing abruptly can cause temporary rebound low mood.

Is ashwagandha good for anxiety and depression?

Yes, particularly for the anxiety-depression overlap. GABA-A agonism addresses anxiety directly; HPA modulation addresses the stress-depression pathway. DASS-21 trials show improvements across all three subscales.

What dose of ashwagandha is used for depression?

Clinical studies use KSM-66 at 300 mg twice daily (600 mg/day) for 8 to 12 weeks. Start at 300 mg/day and increase gradually while monitoring for emotional blunting.

Can I take ashwagandha with antidepressants?

No established interactions exist with common antidepressants. Additive sedation is possible with sedating antidepressants. Always discuss with your prescribing doctor before adding any supplement to an antidepressant regimen.

How long does ashwagandha take to help with depression?

Minimum 4 weeks for mood effects; most clinical evidence comes from 8 to 12 week trials. Cortisol changes are measurable at 4 weeks; mood improvements typically follow over the following month.